Oncotarget

Meta-Analysis:

Associations between dietary folate intake and risks of esophageal, gastric and pancreatic cancers: an overall and dose-response meta-analysis

Wen Liu, Heng Zhou, Yaoqi Zhu and Chaorong Tie _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:86828-86842. https://doi.org/10.18632/oncotarget.18775

Metrics: PDF 1204 views  |   HTML 2455 views  |   ?  


Abstract

Wen Liu1,*, Heng Zhou1,*, Yaoqi Zhu2,3 and Chaorong Tie3

1Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, P. R. China

2Department of Stomatology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei Province, P. R. China

3Department of Stomatology, Taikang Tongji Hospital, Wuhan, 430000, Hubei Province, P. R. China

*These authors have contributed equally to this work

Correspondence to:

Chaorong Tie, email: 414825917@qq.com

Heng Zhou, email: hengzhou117@163.com

Keywords: esophageal cancer, gastric cancer, pancreatic cancer, dose-response analysis, meta-analysis

Received: February 20, 2017    Accepted: May 22, 2017    Published: June 28, 2017

ABSTRACT

There are still some controversies on the association between dietary folate intake and the risk of upper gastrointestinal cancers including esophageal, gastric and pancreatic cancers. Hence, a comprehensive meta-analysis on all available literatures was performed to clarify the relationship between dietary folate intake and risks of upper gastrointestinal cancers. An electric search was performed up to December 12th, 2016 within the PubMed, MEDLINE AND EMBASE databases. Ultimately, a total of 46 studies which evaluated the association between folate intake and risks of upper gastrointestinal cancers were included. According to the data from included studies, the pooled results showed significant association between folate intake and esophageal (OR = 0.545, 95%CI = 0.432-0.658), gastric (OR=0.762, 95%CI=0.648-0.876) and pancreatic (OR=0.731, 95%CI=0.555-0.907) cancers. Linearity dose-response analysis indicated that with 100μg/day increment in dietary folate intake, the risk of esophageal, gastric and pancreatic cancers would decrease by 9%, 1.5% and 6%, respectively. These findings indicated that higher level of dietary folate intake could help for preventing upper gastrointestinal cancers including esophageal, gastric and pancreatic cancers.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 18775